International Cannabis Weekly: 304

CANNABIS THE MOST COMMONLY CONSUMED DRUG IN EUROPE – LATEST REPORT

According to the latest European Drug Report cannabis is the most commonly used drug in Europe. The report published by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) gives an overview of the key trends in drug use across the EU.

READ MORE  »

EXPERTS ACROSS EUROPE URGE HHC TO BE REGULATED RATHER THAN BANNED

READ MORE »

IS EU-GMP CERTIFICATION REALLY NECESSARY FOR CANNABIS CULTIVATORS?

READ MORE »

• Albania takes a step closer to the legalisation of cultivating medical cannabis. 
• German cannabis social clubs push for changes to leaked cannabis bill to ensure effective and sustainable regulation.
• Cannovum Cannabis AG announces ‘Outsourcing’ of medical cannabis business & new CEO.
• University researchers set to explore the feasibility of using cannabis to remediate soil contaminated by PFAS.
• New survey shows the majority of Irish doctors favour the decriminalisation of cannabis for personal use.
• Germany’s revised cannabis legalisation bill to be submitted to the cabinet by mid-August.

READ WEEKLY STOCK REPORT »

• Alabama set to pause all proceedings related to the issuing of medical cannabis business licences.
• Latest US research shows that the combination of THC and CBD can effectively combat acute migraines.
• Nevada governor signs large-scale cannabis reform bill that more than doubles legal personal possession limit.
• Governor of Vermont allows significant medical cannabis reform legislation to become law.
• Regulators in Georgia open doors for medical patients to have far greater access to treatment.
• California localities that support cannabis dispensaries set to receive cash injection of $4.1million funding.

• Canada’s Indiva Limited announces closing of private placement agreement with Canopy Growth.
• Canadian cannabis producer Green Karat enters German craft cannabis market in partnership with Cantourage.
• New data shows fewer incidents between youth and police since recreational cannabis legalisation in Canada.
• Canada’s High Tide releases latest financial report – highlighting third consecutive quarter of record revenue.
• Toronto’s IRC launches new innovative cannabis event insurance product – a first in Canada.
• Alberta Group working to increase Canada’s cannabis market through insurance.

Atalis, Europe’s wholesale cannabis marketplace, will be showcased at ICBC in Berlin next week (29-30 June). Visit the Atalis team at Booth 538 for a live platform demonstration. Short on time? Skip the queues and book a meeting in advance.

BOOK A MEETING »

• Colombia’s Senate rejects legislation to decriminalise sales of cannabis for recreational purposes to adults.
• Governor vetoes medical cannabis, but assembly approves bill in Rondônia, Brazil.
• Xebra announces collaboration agreement with Chapingo University to cultivate cannabis in Mexico.
• Hundreds take to the streets to demand the decriminalisation of cannabis in São Paulo, Brazil.

• ‘Modest and responsible’ legalisation bill introduced in three Australian states by Legalise Cannabis Party.
• Australian researchers report increase in patients seeking medical cannabis prescriptions.
• GlaxoSmithKline’s consumer healthcare division, Haleon, ends partnership with Cann Group after unsuccessful S3 trial.
• Canadian cannabis company, Heritage, ships 15,000 live resin cartridges to Australia.

• Israel’s Tikun Olam-Cannbit set to be acquired by local entrepreneur Ronan Elad.
• Israel’s Finance Committee settles on cost of medical cannabis licence and monthly usage permits.